It is intended to provide a malaria vaccine which contains one member selected from among the following substances (1) to (3): (1) a polypeptide containing the amino acid sequence of malaria parasite GPI8P transamidase； (2) a polypeptide containing a partial amino acid sequence of malaria parasite GPI8P transamidase, wherein the partial amino acid sequence consists of six or more amino acids, and having an immunogenicity； and (3) an expression vector which is capable of expressing the polypeptide (1) or (2).
